Virion Biotherapeutics Company
Virion’s mission is a developer of biological antivirals creates to offer improved therapeutics for respiratory viral infections. The company's antivirals focus on prevention and treatment of influenza and respiratory syncytial virus (RSV), enabling doctors to get a broad-spectrum therapy for respiratory viral infections, potentially simplifying and accelerating treatment by removing the need for differential diagnosis.
Connections
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2017-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
Abingworth, DARPA
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Vanessa King